Large portfolio of novel bacteria to fight cancer
Redbiotec is currently engineering and producing a number of novel bacteria strains to fight cancer.
The Summit summit – World record holder Dani Arnold for fastest Matterhorn climb boosting Redbiotec
Dani Arnold, one of world's top mountaineers and climbers, world speed record holder of Matterhorn North Face joins Redbiotec.
Upgrade of Redbiotec’s operations to biosafety level 2 plus (BSL-2+)
Redbiotec has successfully upgraded its lab infrastructure to biosafty level 2 plus (BSL-2+).
Cancer Research Expert joining Redbiotec
Prof. Mark Tagney, Principal Investigator at Cork Cancer Research Center new on board of Redbiotec.
Celebrating Redbiotec’s 10th anniversary in Schloss Au
Some impressions of our beautiful 10th anniversary event - now with pictures!
Ongoing high interest in Redbiotec/ oversubscription of Redbiotec’s latest financing round
Oversubscrition of Redbiotec's latest financing round on May 27 2017.
Top innovator joining Redbiotec
Prof. Dr. Yaakov (Kobi) Benenson, Professor of Synthetic Biology at ETH Zurich, joins Redbiotec's team.
Another HSV-2 vaccine expert joins Redbiotec
Redbiotec announces today the appointment of Research Associate Professor Sita Awasthi from [...]
Three new patents for Redbiotec’s Herpes simplex vaccine program
Redbiotec has filed a new patent application covering its novel [...]
Redbiotec at J.P. Morgan 34th Healthcare Conference in SF
Redbiotec will attend JPM 34th Healthcare Conference in San Francisco starting January [...]